Skip to main content

Grafa News and Videos — Page 922

Grafa Headlines

Latest

Grafa
Insights

WiseTech shares plunge amid federal fraud investigation

  • Federal authorities are investigating WiseTech Global (ASX:WTC) executive chairman Richard White over visa fraud and human trafficking allegations.
  • The ongoing controversy triggered a sharp market sell-off, pulling the WiseTech share price down to $36.88.
  • Institutional investors are reassessing sector governance and operational risk amid wider software industry headwinds.
Read more: WiseTech shares plunge amid federal fraud investigation

Grafa

Replimune receives FDA acceptance of resubmitted BLA for RP1 in advanced melanoma

Replimune (NASDAQ:REPL) announced that the U.S. Food and Drug Administration has accepted for review the company’s resubmitted Biologics License Application for RP1 (vusolimogene oderparepvec) in combination with nivolumab for the treatment of advanced melanoma.

Read more: Replimune receives FDA acceptance of resubmitted BLA for RP1 in advanced melanoma

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift